Zerodha founder Nithin Kamath reveals that the broker’s Margin Trading Facility has captured 5% market share despite limited ...

A glitch in content delivery service firm Cloudflare, due to the rollout of a system update, disrupted operations of several online platforms, including trading apps like Zerodha and Groww and graphic ...

Zerodha issued an official statement citing the Cloudflare cross-platform downtime as the reason behind the sudden outage on Friday, 5 December 2025.(Screengrab via Nikhil Kamath (X / Twitter)) Online ...

Zerodha and Groww have confirmed that their platforms are fully operational again after a brief Cloudflare outage affected access for thousands of users. The disruption impacted login sessions, order ...

Online brokerage firm Zerodha, on Friday, 5 December 2025, issued an official statement citing the Cloudflare cross-platform downtime as the reason behind the sudden outage. The company also ...

Nikhil Kamath, co-founder of Zerodha, has unveiled a second teaser for his upcoming podcast featuring Elon Musk. The clip reveals a candid conversation about Musk's physique, his fascination with the ...

The story of Nikhil Kamath is a powerful reminder that great ideas often come from simple beginnings and taking risks. Renowned as the co-founder of Zerodha, Kamath has amassed a fortune of $2.5 ...

Kite, an artificial intelligence (AI)-powered payments blockchain, rolled out its native token on Monday, generating significant trading volume on South Korean exchanges Upbit and Bithumb. The token ...

Broking major Zerodha is set to allow its users to invest in US stocks via GIFT City, starting next quarter, founder and CEO Nithin Kamath announced during an AMA with the company’s leadership team.

Gilead Sciences' Kite Pharma is doubling down on in vivo CAR-T, this time inking a deal worth up to $1.64 billion biobucks with Chinese biotech Pregene Biopharma. Kite has paid out $120 million ...

Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...

CREATING NEW NON-CAREER, POLICY-ORIENTED EMPLOYEES IN THE FEDERAL GOVERNMENT: Today, President Donald J. Trump signed an Executive Order creating a new classification of non-career federal workers, ...